Literature DB >> 2811597

Tissue distribution of cocaine in the pregnant rat.

C L DeVane1, J W Simpkins, R L Miller, S B Braun.   

Abstract

Cocaine hydrochloride was administered by single intraperitoneal (IP) doses to pregnant rats at day 18 or 19 of gestation. Plasma and tissue cocaine and norcocaine concentrations were measured by high-pressure liquid chromatography. Pharmacokinetic analysis of concentration versus time data showed rapid distribution of cocaine and its metabolite to maternal and fetal tissues. The area under the cocaine concentration versus time curve (AUC) in fetus compared to maternal plasma was 3.33. The half-life of cocaine in the maternal plasma and fetus was 46 and 55 minutes, respectively, similar to values reported for cocaine elimination half-life in human plasma. The order of cocaine concentrations was placenta greater than fetal liver greater than maternal heart greater than whole fetus greater than fetal brain greater than maternal brain = maternal plasma. Norcocaine concentrations were usually less than 20% of cocaine concentrations in plasma and tissues. These results support extensive fetal exposure to cocaine following administration to pregnant rodents. Pharmacodynamic studies of cocaine in pregnancy should consider the effects of the drug on the developing fetus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2811597     DOI: 10.1016/0024-3205(89)90129-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

1.  Plasma cocaine levels, metabolites, and locomotor activity after subcutaneous cocaine injection are stable across the postpartum period in rats.

Authors:  Michael P Wansaw; Shen-Nan Lin; Joan I Morrell
Journal:  Pharmacol Biochem Behav       Date:  2005-08-22       Impact factor: 3.533

Review 2.  Pharmacokinetics of cocaine in pregnancy and effects on fetal maturation.

Authors:  R C Wiggins
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

3.  Neuroimaging of prenatal drug exposure.

Authors:  Diana L Dow-Edwards; Helene Benveniste; Marylou Behnke; Emmalee S Bandstra; Lynn T Singer; Yasmin L Hurd; L R Stanford
Journal:  Neurotoxicol Teratol       Date:  2006 May-Jun       Impact factor: 3.763

4.  Dose-response cocaine pharmacokinetics and metabolite profile following intravenous administration and arterial sampling in unanesthetized, freely moving male rats.

Authors:  R M Booze; A F Lehner; D R Wallace; M A Welch; C F Mactutus
Journal:  Neurotoxicol Teratol       Date:  1997 Jan-Feb       Impact factor: 3.763

5.  Cocaine exposure in vitro induces apoptosis in fetal locus coeruleus neurons by altering the Bax/Bcl-2 ratio and through caspase-3 apoptotic signaling.

Authors:  S Dey; C F Mactutus; R M Booze; D M Snow
Journal:  Neuroscience       Date:  2006-11-03       Impact factor: 3.590

Review 6.  Short- and long-term adverse effects of cocaine abuse during pregnancy on the heart development.

Authors:  Kurt D Meyer; Lubo Zhang
Journal:  Ther Adv Cardiovasc Dis       Date:  2009-02

7.  Continuous, real-time monitoring of cocaine in undiluted blood serum via a microfluidic, electrochemical aptamer-based sensor.

Authors:  James S Swensen; Yi Xiao; Brian S Ferguson; Arica A Lubin; Rebecca Y Lai; Alan J Heeger; Kevin W Plaxco; H Tom Soh
Journal:  J Am Chem Soc       Date:  2009-04-01       Impact factor: 15.419

8.  Direct effect of cocaine on epigenetic regulation of PKCepsilon gene repression in the fetal rat heart.

Authors:  Kurt Meyer; Haitao Zhang; Lubo Zhang
Journal:  J Mol Cell Cardiol       Date:  2009-06-16       Impact factor: 5.000

9.  Cocaine differentially inhibits neuronal differentiation and proliferation in vitro.

Authors:  D Zachor; J K Cherkes; C T Fay; I Ocrant
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

10.  Prenatal Cocaine Exposure Upregulates BDNF-TrkB Signaling.

Authors:  Andres Stucky; Kalindi P Bakshi; Eitan Friedman; Hoau-Yan Wang
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.